Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-17 Sale | 2021-03-18 8:44 pm | Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer | 6,497 | $11.01 | $71,556 | 71,503 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-06 Option Award | 2023-03-08 4:58 pm | N/A 2032-03-24 | Third Harmonic Bio Inc. | THRD | Ho Robert Chief Financial Officer | 598,955 | $0 | 598,955 (Direct) | View |
| 2023-03-06 Disposition | 2023-03-08 4:58 pm | N/A 2032-03-24 | Third Harmonic Bio Inc. | THRD | Ho Robert Chief Financial Officer | 462,955 | $0 | 598,955 (Direct) | View |
| 2022-10-25 Option Award | 2022-10-27 4:51 pm | N/A 2032-10-24 | Third Harmonic Bio Inc. | THRD | Ho Robert Chief Financial Officer | 95,000 | $0 | 95,000 (Direct) | View |
Ownership | 2022-09-14 6:11 pm | N/A 2032-03-24 | Third Harmonic Bio Inc. | THRD | Ho Robert Chief Financial Officer | 0 | $0 | 367,955 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 4:36 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 4:14 pm | N/A 2031-08-03 | Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer | 190,000 | $0 | 190,000 (Direct) | View |
| 2021-03-16 Exercise | 2021-03-18 8:44 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer | 25,000 | $0 | 71,503 (Direct) | View |
| 2020-08-10 Option Award | 2020-08-12 4:10 pm | N/A 2030-08-10 | Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2020-03-16 Option Award | 2020-03-16 9:39 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer | 275,000 | $0 | 275,000 (Direct) | View |
Ownership | 2020-03-16 9:38 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer | 0 | $0 | 3,000 (Direct) | View |